Regulatory and search intelligence for peptide companies
What happened, where, when, and what it changes for search and content. Every brief links to its primary source, separates confirmed fact from our interpretation, and says where legal interpretation belongs. We track FDA and FTC actions, state enforcement, manufacturer litigation, platform advertising policy and the payment-processor rules our clients live under.
- Lilly v. Astra Peptides: research-use-only framing has to be identical everywhere
Eli Lilly filed suits against retatrutide sellers on 12 August 2026 arguing research-use-only labels do not survive marketing implying human use. What changed, the jurisdictions, and the search and content implications for peptide companies.
- What the 2026 FDA enforcement record means for research-peptide websites
What FDA warning letters and the 2026 telehealth enforcement wave mean for research-peptide marketing: sameness claims, implied approval, sourcing ambiguity, and what a peptide website should not say.
- Processor scanners read nouns, not intent: wording on peptide money pages
Why research-peptide product pages fail processor underwriting even when correctly hedged: scanners match nouns, not intent. The term classes that trigger reviews and how we gate pages against them.
How the rule store works
Every term or claim we treat as sensitive carries a status: green (ordinary approved wording), amber (needs context, substantiation or review), red (disallowed by client policy, platform policy or an authoritative instruction), changed (previously usable, status changed) or unknown (escalate before publication). Each rule records its source, jurisdiction or platform, effective and review dates, scope and notes. Before publication, every title, description, heading, body, table, FAQ, structured-data block, alt text, anchor and CTA is scanned. A match reports "review required, potential conflict with [rule]" with the source and a suggested safer wording where appropriate. Nothing in the store is invented by a model; every non-client rule has a public source.
PeptidesSEO provides search-marketing services and publishes search-marketing analysis. We are not physicians, pharmacists, lawyers or regulatory consultants, and nothing on this site is medical, legal or regulatory advice. Clients remain responsible for obtaining qualified advice about their products, claims, jurisdictions and operations.